Ocean Star Technology Group Limited

Ocean Star Technology Group Limited

HHKEX:8297
0.02
HKD
+0.00
(+5.00%)
-0.04EPS
348.45MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.1
0.1
0.19
0.16
0.14
0.12
0.1
0.08
0.05
0.04
0.03
0.02
0.04
Basic EPS, GAAP
0.01
0.02
- -
- -
-0.05
-0.09
0.01
-0.03
-0.04
-0.03
-0.03
- -
-0.04
Free Cash Flow per Basic Share
0.03
0.02
0.05
-0.02
-0.04
- -
0.02
-0.04
-0.03
-0.01
-0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.02
0.03
- -
0.08
0.03
-0.06
-0.05
0.01
0.01
-0.01
-0.02
-0.02
- -
Tangible Book Value per Share
0.02
0.03
- -
0.08
0.03
-0.06
-0.05
0.01
0.01
-0.01
-0.02
-0.02
- -
Basic Weighted Avg Shares
533
533
400
496
533
533
533
563
813
1,019
1,123
1,294
983
Sales/Revenue/Turnover
51
56
78
79
73
63
53
47
45
41
30
27
42
Operating Margin (%)
23.48
26.94
4.75
5.11
-34.49
-23.42
17.67
-16.66
-48.67
-48.31
-90.14
-1.82
-53.62
Depreciation Expense
1
2
2
3
5
13
13
12
16
12
8
2
- -
Net Income, GAAP
7
8
1
-1
-24
-47
4
-19
-35
-27
-30
-5
-37
Effective Tax Rate (%)
16.17
21.89
70.57
- -
- -
- -
16.36
- -
- -
- -
- -
- -
- -
Profit Margin (%)
14.69
15.17
1.36
-1.67
-33.51
-74.91
6.93
-40.37
-77.69
-65.97
-101.64
-19.44
-87.05
Working Capital
3
12
-4
27
-36
-62
-55
-15
-11
-20
-26
-32
-20
LT Debt
1
1
- -
1
1
8
4
7
6
1
1
1
2
Total Equity
9
18
3
40
16
-32
-29
7
13
-9
-26
-31
1
Return on Invested Capital (%)
- -
54.43
30.56
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
57.04
9.06
- -
- -
- -
-30.75
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
63.83
10.45
-6.16
-86.78
- -
- -
- -
-350.44
- -
- -
- -
-333.83

Capital Structure

HKD

•

in mil. unless spec.
Mar'23
Jun'24
Sep'24
ST Debt
10
- -
8
LT Borrowings
- -
- -
- -
LT Finance Leases
6
- -
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,010
1,010
1,010
Market Capitalization
145
318
348

Working Capital

HKD

•

in mil. unless spec.
Mar'23
Jun'24
Sep'24
Total Current Assets
63
- -
53
Cash, Cash Equivalents & STI
29
- -
13
Accounts Receivable, Net
- -
- -
10
Inventories
21
- -
20
Total Current Liabilities
74
- -
72
Payables & Accruals
- -
- -
- -
ST Debt
10
- -
8
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
105.13%
2.93%
21.31%
Free Cash Flow
-159.65%
-102.93%
-142.79%
Net Income, GAAP
79.82%
-123.45%
-82.52%
Sales/Revenue/Turnover
-5.67%
-12.32%
-8.57%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
41
2025
6
- -
30
2026
- -
- -
27

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.03
2025
-0.01
- -
-0.03
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Yan Hui Hu
Full Time Employees
43
Sector
Consumer non-durables
Industry
Apparel/Footwear
Address
Kai Tak Commercial Building Hong Kong Hong Kong
IPO Date
Jul 13, 2017
Business
Ocean Star Technology Group Limited Ocean Star Technology Group Limited (8297.HK), an investment holding company, designs, manufactures, and sells lingerie products primarily in the People's Republic of China, Macau, and Hong Kong. The company operates through Lingerie Products and Others segments, offering core shaping lingerie such as bras, panties, body shaping underwear, and chest support vests; additional products including breast cream, swimwear, bra straps and pads, waist bands, and nude bras; and related services encompassing beauty treatments, lingerie alteration, retail sales of lingerie, social influencers agency through an online platform, and money lending. It markets its products under the Bodibra, June, ooobiki, Bodicare, and invisi brands, targeting female consumers seeking body enhancement and intimate apparel solutions. Founded in 2003 and headquartered in Kwun Tong, Hong Kong, the company changed its name from My Heart Bodibra Group Limited in September 2021. Recent developments include a strategic cooperation framework agreement with Shiyanli Shuangmei for biotechnology-related technical services and product promotion in the PRC's "big health" sector, particularly dermatology, executed in late 2023; multiple executive director appointments in 2024 and 2025, such as Hu Yanhui effective November 2025, alongside Tian Sun as Executive Chairman, Lizhu Chen, Xueling Yang, Mingyuan Yang, and Ying Zhou; and ongoing board enhancements with independent non-executive directors.